Delivery Order SPE2DB24D2216-SPE2DB25FGNBE

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $57K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cetirizine 5mg, 100 tablets, with a ceiling value of $2,495.47. The contract has an ultimate completion date of August 21, 2024 and does not utilize any set-aside designations. As a key supplier to the federal government, Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,726.63, is for the delivery of 4,567,410,467 units of Cetirizine HCL 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of February 28, 2025. The contract was awarded on February 27, 2025 and does not have a set-aside designation. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,470,827 units of cetirizine hydrochloride 10 mg tablets, a common over-the-counter allergy medication. The fixed-price contract has a ceiling value of $1,331.01 and an ultimate completion date of August 16, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,713,078 units of Cetirizine HCL 10 mg tablets. The firm-fixed-price delivery order, valued at $3,258.96, has a period of performance through May 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.71, is a Delivery Order for the supply of 4,566,731,869 units of Cetirizine HCL 10 mg Tablets in 100-count packages. The contract has a period of performance through December 17, 2024, with a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery...
This is a $5,337.97 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 4,565,213,468 units of Cetirizine HCL 5 mg tablets in 100-count bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,127.36 firm-fixed-price delivery order is for the supply of CETIRIZINE-PSE ER 5-120 MG TAB 12S, a type of pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The contract is a firm fixed-price delivery order with a total ceiling value of $15,593.87 and an ultimate completion date of November 3, 2023. This order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,347.25, is for the procurement of Cetirizine HCL 10 mg tablets, a common antihistamine medication. The contract is a firm-fixed-price delivery order with a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGNBE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine HCL 10 mg tablets. The contract has a firm fixed price, with a ceiling value of $57,426.15, and runs through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.

Generated 6/6/25, 9:48 AM